Deep Dive, Manufacturing

Planning a clinical supply program? Don’t overlook primary packaging.

Image courtesy of Catalent Pharma Solutions © 2017 Catalent, Inc. All rights reserved

When planning a clinical trial, primary packaging — the materials that come into direct contact with the study drug — may not seem like a big priority for drug development executives. And that would be a mistake.

As we'll learn, packaging and presentation is crucial to study success. Drug stability, regulatory strategy, and patient-centered design are just some of the factors to consider. In this Deep Dive, we talked with scientific experts at contract development and manufacturer Catalent and explored these questions:

  • How does packaging change from small phase I trials to large multi-center phase III efforts?
  • What are the best packaging strategies to achieve longer stability?
  • What are the differences between the US and Europe for expiry dates on packaging?
  • Can you best source comparator therapies without being charged a fortune?
  • How can developers best package for adherence?

Planning a clinical supply program? Keep reading for answers to these questions and many more.

In order to read this article, you must be an Endpoints News subscriber. (It's free to subscribe.)

← Go back

We produce two daily email newsletters designed to give you a complete picture of what's important in biopharma. It's free to subscribe and never any spam. Join 44,000+ biopharma executives who read Endpoints News every day.

Sponsored by Catalent.
Access is subject to the terms in our Privacy Policy.